| 4 IntroductionsBH.pdf |
| 4-CoverageClinicalTrials_02-05-2016.pdf |
| 4a Open Enrollment Communication_Results (final).pdf |
| 4a Update On Transition of Specialty Medications (final).pdf |
| 4A-Sept2015FinancialRpt_11-20-15.pdf |
| 4b CVS Implementation and Communications Outreach (final).pdf |
| 4B Eligibility and Enrollment Services Contract (final).pdf |
| 4B-CY2015Q3ActuarialForecastUpd_11-20-15.pdf |
| 4c 2016 Membership Satisfacton Survey (final).pdf |
| 4C-StateHealthPlanTrends_11-20-15.pdf |
| 4d 2017 Communication and Marketing Strategy (final).pdf |
| 5 - MOU DIT for GDAC (final).pdf |
| 5 Open Enrollment Strategy for 2018 (final).pdf |
| 5-2018 Benefit Design Changes (final).pdf |
| 5-ProviderReimburseStratsAndOpp_02-05-2016.pdf |
| 5A B State Budget SHP Related Legislation (final).pdf |
| 5a 2017 Benefit Design Changes (final).pdf |
| 5a Oct 2016 Financial Report (final).pdf |
| 5A PT Committee Meeting Summary (final).pdf |
| 5a Update On Transition of Speciality Medications (final).pdf |
